MENU
PTGX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Protagonist Therapeutics (PTGX) Ownership - Who owns Protagonist Therapeutics?
Industry: @Biotechnology
Profile
Industry
Biotechnology
Address
7707 Gateway Boulevard
Phone
+1 510 474-0170
Employees
112
Web
https://www.protagonist-inc.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
2.18B
P/E Ratio
13.34
Total Cash
468.72M
Projected Growth
N/A
Total Debt
10.9M
Revenue
323.8M
Risk (Beta)
1.93
Dividend Yield
N/A
Total Cash/Share
7.86
Total Debt/Equity
N/A
Revenue/Share
5.09 USD as % of share price
Fundamentals
PTGX
Capitalization
2.18B
P/E Ratio
13.34
Risk (Beta)
1.93
Dividend Yield
N/A
Total Cash
469M
Total Cash/Share
7.86
Total Debt
10.9M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
5.09%
Revenue
324M
ROE
N/A
Book Value
532M
P/B Ratio
4.09
Cash Flow
N/A
Earnings
2.86
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
1K
Current Ratio
10.70
Current Revenue Per Employee
37103.18
Dividends Per Share - Security
N/A
EBITDA
152M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
36.59
Shares Held By Institutions
3.98B
Shares Outstanding - Current
59.6M
Total Liabilities
71.9M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-5.337
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of disulfide-rich peptides
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
7707 Gateway Boulevard
Phone
+1 510 474-0170
Employees
112
Web
https://www.protagonist-inc.com